Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower-Grade Gliomas

Figure 5

Kaplan-Meier survival analysis for LGG patients according to GAS5 expression levels, stratified by clinicopathological risk factors. (a, b) Tumour size. (c, d) Tumour grade. P values were calculated using the log-rank test.

(a)

(b)

(c)

(d)